279 related articles for article (PubMed ID: 17532348)
1. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine.
Bolayirli IM; Aslan M; Balci H; Altug T; Hacibekiroglu M; Seven A
Life Sci; 2007 Jun; 81(2):121-7. PubMed ID: 17532348
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.
Harangi M; Seres I; Varga Z; Emri G; Szilvássy Z; Paragh G; Remenyik E
Eur J Clin Pharmacol; 2004 Dec; 60(10):685-91. PubMed ID: 15490140
[TBL] [Abstract][Full Text] [Related]
3. Effects of atorvastatin therapy on protein oxidation and oxidative DNA damage in hypercholesterolemic rabbits.
Aydin S; Uzun H; Sozer V; Altug T
Pharmacol Res; 2009 Apr; 59(4):242-7. PubMed ID: 19429465
[TBL] [Abstract][Full Text] [Related]
4. Ameliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits.
Sozer V
Fundam Clin Pharmacol; 2015 Dec; 29(6):558-66. PubMed ID: 26456720
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
6. The effects of atorvastatin on antioxidant/antiinflammatory properties of HDLs in hypercholesterolemics.
Akalin Çiftçi G; Ertorun İ; Akalin A; Alataş İÖ; Musmul A
Turk J Med Sci; 2015; 45(2):345-51. PubMed ID: 26084126
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.
Sezer ED; Sozmen EY; Nart D; Onat T
Vasc Health Risk Manag; 2011; 7():333-43. PubMed ID: 21731885
[TBL] [Abstract][Full Text] [Related]
8. Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia.
Bolaman Z; Kadikoylu G; Ozgel N; Yenisey C
J Natl Med Assoc; 2006 Aug; 98(8):1273-7. PubMed ID: 16916124
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
10. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
[TBL] [Abstract][Full Text] [Related]
11. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals.
Thomas MK; Narang D; Lakshmy R; Gupta R; Naik N; Maulik SK
Cardiovasc Drugs Ther; 2006 Feb; 20(1):37-44. PubMed ID: 16534549
[TBL] [Abstract][Full Text] [Related]
12. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status.
Nagila A; Permpongpaiboon T; Tantrarongroj S; Porapakkham P; Chinwattana K; Deakin S; Porntadavity S
Pharmacol Rep; 2009; 61(5):892-8. PubMed ID: 19904013
[TBL] [Abstract][Full Text] [Related]
14. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
Am J Cardiol; 2004 Aug; 94(4):497-500. PubMed ID: 15325939
[TBL] [Abstract][Full Text] [Related]
15. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
[TBL] [Abstract][Full Text] [Related]
17. The effects of atorvastatin on oxidative stress in L-NAME-treated rats.
Sozer V; Uzun H; Gelisgen R; Kaya M; Kalayci R; Tabak O; Arican N; Konukoglu D
Scand J Clin Lab Invest; 2013 Oct; 73(7):591-7. PubMed ID: 24024670
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats.
Zheng D; Liang Q; Zeng F; Mai Z; Cai A; Qiu R; Xu R; Li D; Mai W
Lipids Health Dis; 2015 May; 14():41. PubMed ID: 25934565
[TBL] [Abstract][Full Text] [Related]
19. Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment.
Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Semecky V
Can J Physiol Pharmacol; 2007 Aug; 85(8):767-73. PubMed ID: 17901886
[TBL] [Abstract][Full Text] [Related]
20. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
